DOCSLIB.ORG

Áiáëiîòåêà Ñòóäåíòà-Ìåäèêà Medical Student's Library

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Áiáëiîòåêà Ñòóäåíòà-Ìåäèêà Medical Student's Library Áiáëiîòåêà ñòóäåíòà-ìåäèêà Medical Student’s Library GENERAL PHARMACOLOGY GENERAL PHARMACOLOGY ОДЕСЬКИЙ МЕДУНІВЕРСИТЕТ Medical Student’s Library Initiated in 1999 to mark the Centenary of the Odessa State Medical University (1900 — 2000) Edited and Published by V. M. ZAPOROZHAN, the State Prize-Winner of Ukraine, Academician of the Academy of Medical Sciences of Ukraine CHIEF EDITORIAL BOARD V. M. ZAPOROZHAN, (Chief Editor), Yu. I. BAZHORA, I. S. VITENKO, V. Y. KRESYUN (Vice Chief Editor), O. O. MARDASHKO, V. K. NAPKHANYUK, G. I. KHANDRIKOVA(Senior Secretary), P. M. TCHUYEV The Odessa State Medical University Dear Reader, When in 1999 the lecturers and researchers of the Odessa State Medi- cal University started issuing a series of books united by the collection en- titled “Medical Student’s Library” they had several aims before them. Firstly, they wanted to add new books to the Ukrainian library of med- ical literature that would be written in Ukrainian, the native language of the country. These books should contain both classical information on med- icine and the latest information on the state of the art, as well as reflect extensive experience of our best professionals. Secondly, our lecturers and specialists wanted to write such books which reflected the newest subjects and courses that have recently been introduced into the curricula, and in general there have been no textbooks on these subjects and courses at that time. These two aims have successfully been coped with. Some dozens of text- books and workbooks published in these years have become a good con- tribution of their authors and publishers to the development and making of the Ukrainian national educational literature. The next step that we decided to undertake was to issue a unique series of books in foreign languages. The foreign students taking their medical ed- ucation in the Ukraine, our University included, are expecting such books to be published. Other countries are also waiting for them as the Odessa State Medical University is a Fellow Member of the International and European Association of Universities. Our Medical University is over a hundred years old and has long since become a center of various original medical schools and trends. These are headed by well-know medical professionals whose competence is acknowledged not only in this country, but abroad as well. Valery ZAPOROZHAN, Editor-in-Chief of the Series “Medical Student’s Library” the State Prize-Winner of Ukraine, Academician of the Academy of Medical Sciences of Ukraine GENERAL PHARMACÎLÎGY COURSE OF LECTURES Odessa The Odessa State Medical University 2005 UDC 615:378.16=20 BBC 52.81Я93 Authors: V. Y. Kresyun, D. Yu. Andronov, K. F. Shemonaeva, V. V. Godovan, G. G. Vidavska, P. B. Antonenko Reviewers: Professor V. D. Lukyanchuk, M.D., the Chair of the Pharmacology Department of the Lugansk State Medical University, Ukraine Professor V. I. Mamchur, M.D., the Chair of the Pharmacology Department of the Dnepropetrovsk Medical Academy, Ukraine The lectures are designed according to pharmacological drug groups due to their ef- fects on particular body systems and intended for the 3rd year students of medical facul- ty. Information is organized according to the sequence used in many International and Ukrainian pharmacology courses. The textbook is intended for students of higher medi- cal institutions. Загальна фармакологія: Курс лекцій: Навч. посібник / В. Й. Кресюн, Д. Ю. Андронов, К. Ф. Шемонаєва та ін. — Одеса: Одес. держ. мед. ун-т, 2005. — 215 с. — (Б-ка студента-медика). — Мова англ. ISBN 966-7733-80-7 Курс лекцій для студентів 3-го курсу медичного факультету складається з розділів, упорядкованих за фармакологічними групами ліків згідно з їх ефектами на специфічні системи органів. Матеріал викладено у послідовності, використову- ваній у багатьох міжнародних й українських виданнях з фармакології. Для студентів вищих навчальних медичних закладів. Іл. 30. Табл. 15. Бібліогр.: 37 назв. ББК 52.81Я93 Рекомендовано до видання Центральною координаційно-методичною радою Одеського державного медичного університету Протокол № 5 від 18.05.2005 © В. Й. Кресюн, Д. Ю. Андронов, К. Ф. Шемонаєва, ISBN 966-7733-47-5 В. В. Годован, Г. Г. Відавська, П. Б. Антоненко, 2005 ISBN 966-7733-80-7 © Одеський державний медичний університет, 2005 6 PREFACE The lectures are designed to provide a complete, Other lectures within each section emphasize up-to-date and readable pharmacology text for the 3rd therapeutic classes of drugs and prototypical or year students of medical faculty. Planned to be used commonly used individual drugs, those used to treat during the 2 semesters, the text focuses on the major common disorders, and those likely to be encoun- principles of pharmacology with the clinical ap- tered in clinical practice. Lecture’s content is pre- plication of drugs. It also offers special features that sented in a consistent format and includes a descrip- make it useful to practicing clinicians. tion of a condition for which a drug group is used; The content of Lectures is organized in 10 sec- a general description of a drug group, including a tions, primarily by therapeutic drug groups and their small historic review, mechanism(s) of action, indi- effects on particular body systems. This approach cations for use, and contraindications; adverse drug helps the student make logical connections between effects and descriptions of individual drugs, with major drug groups and the conditions for which they recommended dosages and routes of administration. are used. It also provides a foundation for learning The lectures in these sections include drug names, about new drugs, most of which fit into known groups. classifications, prototypes, drug approval process- Information is organized according to the sequence es. Some lectures include initial parts that reviews used in many pharmacology courses: common pharma- the physiology of body systems. The reviews are de- cology; autonomic drugs; neurotropic agents; cardio- signed to facilitate understanding of drug effects on vascular drugs; endocrine and vitamin drugs; anti- a body system. Each section includes examination microbial agents; drugs used to treat diseases of the questions with detailed answers to help students test blood; and special topics. The first lecture contains their knowledge of the covered material. Appendi- knowledge required to understand the main principles ces contain information about main international and rules of medical prescription. Lecture 2 consists pharmacological abbreviations and examples of of common pharmacological information, including: combination drugs. All of this made the Lectures cellular physiology, drug transport, pharmacokinetic book comprehensive but not exhaustive, and accu- processes, the receptor theory of drug action, types of rate — a text that supplies both students and uni- drug interactions, and factors that influence drug ef- versity faculties. fects on body tissues, dosage forms, routes and meth- These lectures are created at the Department of ods of accurate drug administration and general prin- general and clinical pharmacology of the Odessa State ciples of drug therapy. Medical University. 7 MEDICAL PRESCRIPTION Lecture 1 ument, because it is observed when the correctness of treatment is doubtful. INTRODUCTION TO THE MEDICAL PRESCRIPTION RULES PARTS OF PRESCRIPTION OF PRESCRIPTION WRITING 1. Inscriptio — tells official data about the hospital Prescription is a part of pharmacology. It is divid- (title and address), the physician, who writes prescrip- ed into pharmaceutical prescription, which studies tion (surname, initials), and the patient (surname, ini- rules of drug’s production, and medical prescription tials, age). It is written in national language. that studies rules of prescription writing. 2. Prepositio — consisting of the word recipe, take, Drug substances have different sources. They can or its sign, “Rp.:” be obtained from the plants, animals, minerals, bacte- 3. Designatio materiarum (list of agents) is the main ria, and fungi. Drugs, produced from the plants by sim- part of the prescription, containing the names and ple processing (drying and mixing), are called simple. amounts of the drugs ordered. Each drug substance is They are used seldom. Composite drugs are produced written in own line from a capital letter, in genitive from plant origin by more complex processing. For ex- case, and in Latin. Words can not to be shortened and ample, Galen’s and neo-Galen’s drugs. They are both broken. Doses are written by figures. If ingredient is containing sum of plant’s active substances. Galen’s only one, receipt is simple, if many — complex. drug is obtained by spirit or another kind of extrac- Drug substances are divided according to their im- tion from a plant, e.g. tinctures, extracts; usually it portance. contains ballast or non-active substances. However, a. Remedium cardinale (s.basis) — a drug sub- neo-Galen’s drug is subjected to more composite stance, which carries the main treating effect. processing; it is more pure and can be used parenter- b. Remedium adjuvants are substances with an ad- ally. ditive action. Drug form is a shape that is given to the drug sub- c. Remedium constituents — a shape-making sub- stance. According to their condition drug forms are di- stance. A constituent is to be indifferent (non-active). vided into solid, (powders, capsules, tablets, dragee, d. Remedium corrigens — substances bettering granules), liquid (infusions, decoctions, mixtures, tinc- taste, smell, type. Corrigens are usually sugar, ether tures, fluid extracts, solutions), and soft (ointments, flu- oils, syrups. id ointments, pasts, suppositories, plasters). Also drug 4. Subscriptio — directions for mixing of the in- forms can be dosed, they usually act after reaching the gredients and designation of the form (pill, powder, bloodstream, and non-dosed, which as a rule act topi- solution, etc.) in which the drug is to be made, e.g. be- cally. Drug substance is a chemical compound that pro- ginning with the word, misce, mix, or its abbreviation, vides drug’s action. Drug is a drug substance, produced M., fiat, make, or its abbreviation, f., and the name of in a concrete drug form.
Load more

Recommended publications
  • ON ATTRACTION of SLIME MOULD PHYSARUM POLYCEPHALUM to PLANTS with SEDATIVE PROPERTIES 1. Introduction Physarum Polycephalum Belo
    ON ATTRACTION OF SLIME MOULD PHYSARUM POLYCEPHALUM TO PLANTS WITH SEDATIVE PROPERTIES ANDREW ADAMATZKY Abstract. A plasmodium of acellular slime mould Physarum polycephalum is a large single cell with many nuclei. Presented to a configuration of attracting and repelling stimuli a plasmodium optimizes its growth pattern and spans the attractants, while avoiding repellents, with efficient network of protoplasmic tubes. Such behaviour is interpreted as computation and the plasmodium as an amorphous growing biologi- cal computer. Till recently laboratory prototypes of slime mould computing devices (Physarum machines) employed rolled oats and oat powder to represent input data. We explore alternative sources of chemo-attractants, which do not require a sophis- ticated laboratory synthesis. We show that plasmodium of P. polycephalum prefers sedative herbal tablets and dried plants to oat flakes and honey. In laboratory experi- ments we develop a hierarchy of slime-moulds chemo-tactic preferences. We show that Valerian root (Valeriana officinalis) is strongest chemo-attractant of P. polycephalum outperforming not only most common plants with sedative activities but also some herbal tablets. Keywords: Physarum polycephalum, slime mould, valerian, passion flower, hops, ver- vain, gentian, wild lettuce, chemo-attraction 1. Introduction Physarum polycephalum belongs to the species of order Physarales, subclass Myxo- gastromycetidae, class Myxomycetes, division Myxostelida. It is commonly known as a true, acellular or multi-headed slime mould. Plasmodium is a `vegetative' phase, single cell with a myriad of diploid nuclei. The plasmodium looks like an amorphous yellowish mass with networks of protoplasmic tubes. The plasmodium behaves and moves as a giant amoeba. It feeds on bacteria, spores and other microbial creatures and micro- particles (Stephenson & Stempen, 2000).
    [Show full text]
  • Yerevan State Medical University After M. Heratsi
    YEREVAN STATE MEDICAL UNIVERSITY AFTER M. HERATSI DEPARTMENT OF PHARMACY Balasanyan M.G. Zhamharyan A.G. Afrikyan Sh. G. Khachaturyan M.S. Manjikyan A.P. MEDICINAL CHEMISTRY HANDOUT for the 3-rd-year pharmacy students (part 2) YEREVAN 2017 Analgesic Agents Agents that decrease pain are referred to as analgesics or as analgesics. Pain relieving agents are also called antinociceptives. An analgesic may be defined as a drug bringing about insensibility to pain without loss of consciousness. Pain has been classified into the following types: physiological, inflammatory, and neuropathic. Clearly, these all require different approaches to pain management. The three major classes of drugs used to manage pain are opioids, nonsteroidal anti-inflammatory agents, and non opioids with the central analgetic activity. Narcotic analgetics The prototype of opioids is Morphine. Morphine is obtained from opium, which is the partly dried latex from incised unripe capsules of Papaver somniferum. The opium contains a complex mixture of over 20 alkaloids. Two basic types of structures are recognized among the opium alkaloids, the phenanthrene (morphine) type and the benzylisoquinoline (papaverine) type (see structures), of which morphine, codeine, noscapine (narcotine), and papaverine are therapeutically the most important. The principle alkaloid in the mixture, and the one responsible for analgesic activity, is morphine. Morphine is an extremely complex molecule. In view of establish the structure a complicated molecule was to degrade the: compound into simpler molecules that were already known and could be identified. For example, the degradation of morphine with strong base produced methylamine, which established that there was an N-CH3 fragment in the molecule.
    [Show full text]
  • Determination of Quifenadine by HPLC Method in Blood
    ISSN 2311-715X (Print) Український біофармацевтичний журнал, № 3 (64) 2020 ISSN 2519-8750 (Online) UDC 615.218:001.891:543.42:543.544 https://doi.org/10.24959/ubphj.20.277 O.National Mamina, University V. Kabachny, of Pharmacy O. Lozova* of the Ministry of Health of Ukraine * Private Higher Educational Institution “Kyiv Medical University” determination of quifenadine by HPLC method in blood Topicality. - tion H1-histamine receptor blocker. The drug reduces the content of histamine in tissues due to the activation of the enzyme Quifenadine hydrochloride (phencarol) – quinuclidinyl-3-diphenyl carbinol hydrochloride – first genera- diamine oxidase, which breaks down up to 30 % of tissue histamine. Quifenadine hydrochloride is superior to diphenhy dramine in duration of antihistamine action. Unlike diphenhydramine and diprazine, quifenadine does not inhibit the CNS, is characterized by weak sedative properties. Quifenadine hydrochloride can be used in the development of tolerance to other sedative antihistamines. Quifenadine hydrochloride is used to treat anaphylactic shock, urticaria, hay fever, Quincke’s edema, dermatoses, allergic rhinitis, food and drug allergies. In case of overdose of quifenadine hydrochloride- chloridecauses dryness in pharmaceuticals of the mucous and membranes, biological headache, matrices duringvomiting, treatment stomach are pain based and dyspepsia.on the choice At highof highly doses, sensitive it can affect and the cardiovascular system, gastrointestinal tract, liver and kidneys. Detection and quantification of quifenadine hydro antihistamines and diagnosis of drug intoxication. selectiveAim. research methods, which is an urgent task for monitoring the effectiveness of treatment of the population with Materials To develop and methods. an algorithm for directed analysis of quifenadine in biological extracts from blood using a unified method of HPLC research.
    [Show full text]
  • Thesis Rests with Its Author
    University of Bath PHD A modelling study of the ligand-gated ion-channel superfamily of receptors Cockcroft, Victor Barrie Award date: 1992 Awarding institution: University of Bath Link to publication Alternative formats If you require this document in an alternative format, please contact: [email protected] General rights Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright owners and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these rights. • Users may download and print one copy of any publication from the public portal for the purpose of private study or research. • You may not further distribute the material or use it for any profit-making activity or commercial gain • You may freely distribute the URL identifying the publication in the public portal ? Take down policy If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately and investigate your claim. Download date: 08. Oct. 2021 A MODELLING STUDY OF THE LIGAND-GATED ION-CHANNEL SUPERFAMILY OF RECEPTORS. submitted by Victor Barrie Cockcroft for the degree of Ph.D. at the University of Bath 1992 Copyright Attention is drawn to the fact that the copyright of this thesis rests with its author. This copy of the thesis has been supplied on the condition that anyone who con­ sults it is understood to recognize that its copyright rests with its author and that no quotation from the thesis and no information derived from it may be published with­ out the prior written consent of the author.
    [Show full text]
  • Receives Fda Approval for the Treatment of Insomnia
    AMBIEN CR™ (ZOLPIDEM TARTRATE EXTENDED-RELEASE TABLETS) CIV RECEIVES FDA APPROVAL FOR THE TREATMENT OF INSOMNIA First and Only Extended-Release Prescription Sleep Medication Indicated for Sleep Induction and Maintenance Covers Broad Insomnia Population Paris, France, September 6, 2005 - Sanofi-aventis (EURONEXT: SAN and NYSE: SNY) announced today that the U.S. Food and Drug Administration (FDA) has approved AMBIEN CR™ (zolpidem tartrate extended-release tablets) CIV, a new extended-release formulation of the number ® one prescription sleep aid, AMBIEN (zolpidem tartrate) CIV, for the treatment of insomnia. AMBIEN CR is non-narcotic and a non-benzodiazepine, formulated to offer a similar safety profile to AMBIEN with a new indication for sleep maintenance, in addition to sleep induction. AMBIEN CR is the first and only extended-release prescription sleep medication to help people with insomnia fall asleep fast and maintain sleep with no significant decrease in next day performance. AMBIEN CR, a bi-layered tablet, is delivered in two stages. The first layer dissolves quickly to induce sleep. The second layer is released more gradually into the body to help provide more continuous sleep. “Insomnia is a significant public health problem, affecting millions of Americans. Insomnia impacts daily activities and is associated with increased health care costs,” said James K. Walsh, PhD, Executive Director and Senior Scientist, Sleep Medicine and Research Center at St. Luke's Hospital in St. Louis, Missouri. “Helping patients stay asleep is recognized as being as important as helping them fall asleep,” said Walsh. “Ambien CR has shown evidence of promoting sleep onset and more continuous sleep".
    [Show full text]
  • Pharmacology on Your Palms CLASSIFICATION of the DRUGS
    Pharmacology on your palms CLASSIFICATION OF THE DRUGS DRUGS FROM DRUGS AFFECTING THE ORGANS CHEMOTHERAPEUTIC DIFFERENT DRUGS AFFECTING THE NERVOUS SYSTEM AND TISSUES DRUGS PHARMACOLOGICAL GROUPS Drugs affecting peripheral Antitumor drugs Drugs affecting the cardiovascular Antimicrobial, antiviral, Drugs affecting the nervous system Antiallergic drugs system antiparasitic drugs central nervous system Drugs affecting the sensory Antidotes nerve endings Cardiac glycosides Antibiotics CNS DEPRESSANTS (AFFECTING THE Antihypertensive drugs Sulfonamides Analgesics (opioid, AFFERENT INNERVATION) Antianginal drugs Antituberculous drugs analgesics-antipyretics, Antiarrhythmic drugs Antihelminthic drugs NSAIDs) Local anaesthetics Antihyperlipidemic drugs Antifungal drugs Sedative and hypnotic Coating drugs Spasmolytics Antiviral drugs drugs Adsorbents Drugs affecting the excretory system Antimalarial drugs Tranquilizers Astringents Diuretics Antisyphilitic drugs Neuroleptics Expectorants Drugs affecting the hemopoietic system Antiseptics Anticonvulsants Irritant drugs Drugs affecting blood coagulation Disinfectants Antiparkinsonian drugs Drugs affecting peripheral Drugs affecting erythro- and leukopoiesis General anaesthetics neurotransmitter processes Drugs affecting the digestive system CNS STIMULANTS (AFFECTING THE Anorectic drugs Psychomotor stimulants EFFERENT PART OF THE Bitter stuffs. Drugs for replacement therapy Analeptics NERVOUS SYSTEM) Antiacid drugs Antidepressants Direct-acting-cholinomimetics Antiulcer drugs Nootropics (Cognitive
    [Show full text]
  • Assessment of Molecular Action of Direct Gating and Allosteric Modulatory Effects of Carisoprodol (Somartm) on GABA a Receptors
    Graduate Theses, Dissertations, and Problem Reports 2015 Assessment of molecular action of direct gating and allosteric modulatory effects of carisoprodol (SomaRTM) on GABA A receptors Manoj Kumar Follow this and additional works at: https://researchrepository.wvu.edu/etd Recommended Citation Kumar, Manoj, "Assessment of molecular action of direct gating and allosteric modulatory effects of carisoprodol (SomaRTM) on GABA A receptors" (2015). Graduate Theses, Dissertations, and Problem Reports. 6022. https://researchrepository.wvu.edu/etd/6022 This Dissertation is protected by copyright and/or related rights. It has been brought to you by the The Research Repository @ WVU with permission from the rights-holder(s). You are free to use this Dissertation in any way that is permitted by the copyright and related rights legislation that applies to your use. For other uses you must obtain permission from the rights-holder(s) directly, unless additional rights are indicated by a Creative Commons license in the record and/ or on the work itself. This Dissertation has been accepted for inclusion in WVU Graduate Theses, Dissertations, and Problem Reports collection by an authorized administrator of The Research Repository @ WVU. For more information, please contact [email protected]. ASSESSMENT OF MOLECULAR ACTION OF DIRECT GATING AND ALLOSTERIC MODULATORY EFFECTS OF MEPROBAMATE (MILTOWN®) ON GABAA RECEPTORS Manish Kumar, MD, MS Dissertation submitted to the School of Pharmacy at West Virginia University in partial fulfillment of Requirements
    [Show full text]
  • Examination Questions
    EXAMINATION QUESTIONS CHAPTER I. GENERAL PHARMACOLOGY AND PRESCRIPTION 1. Essence of pharmacology as a science. Parts and fields of modern pharmacology. The main terms and concepts of pharmacology – pharmacological activity, action, efficiency. 2. Sources and stages of drug development. Drugs – generics, placebo effects. Definition of such concepts as medicinal agent (medicinal drug, drug), medicinal substance, medicinal form. 3. Routes of drug administration into the body and their characteristic. Presystemic drug elimination. 4. Drug transfer through biological barriers and their types. The main factors influencing on the drug transfer in the body. 5. Drug transfer of variable ionization substances through membranes (Henderson-Hasselbach's equation of ionization). Principles of transfer management. 6. Drug transfer in the body. Aqueous diffusion and lipid diffusion (Fick's diffusion equation). Active transport. 7. Central postulate of pharmacokinetics: concentration of medicinal substance in blood plasma – the main parameter for management of the pharmacological effect. The tasks solved on the basis of this postulate. 8. Pharmacokinetic models (one-compartment and two-compartment), quantitative laws of absorption and drug elimination. 9. Bioavailability of drugs – definition, essence, quantitative expression, determinants. 10. Drug distribution in the body: compartments, ligands, the main determinants of distribution. 11. Elimination rate constant, its essence, dimension, connection with other pharmacokinetic parameters. 12. Excretion half-life of drugs, its essence, dimension, connection with other pharmacokinetic parameters. 13. Clearance as the main parameter of pharmacokinetics for management of the dosing regimen. Its essence, dimension and connection with other pharmacokinetic parameters. 14. Dose. Types of doses. Units of drug dosage. Aims of drug dosage, ways and variants of administration of drugs, dosing interval.
    [Show full text]
  • Herbal Remedies and Their Possible Effect on the Gabaergic System and Sleep
    nutrients Review Herbal Remedies and Their Possible Effect on the GABAergic System and Sleep Oliviero Bruni 1,* , Luigi Ferini-Strambi 2,3, Elena Giacomoni 4 and Paolo Pellegrino 4 1 Department of Developmental and Social Psychology, Sapienza University, 00185 Rome, Italy 2 Department of Neurology, Ospedale San Raffaele Turro, 20127 Milan, Italy; [email protected] 3 Sleep Disorders Center, Vita-Salute San Raffaele University, 20132 Milan, Italy 4 Department of Medical Affairs, Sanofi Consumer HealthCare, 20158 Milan, Italy; Elena.Giacomoni@sanofi.com (E.G.); Paolo.Pellegrino@sanofi.com (P.P.) * Correspondence: [email protected]; Tel.: +39-33-5607-8964; Fax: +39-06-3377-5941 Abstract: Sleep is an essential component of physical and emotional well-being, and lack, or dis- ruption, of sleep due to insomnia is a highly prevalent problem. The interest in complementary and alternative medicines for treating or preventing insomnia has increased recently. Centuries-old herbal treatments, popular for their safety and effectiveness, include valerian, passionflower, lemon balm, lavender, and Californian poppy. These herbal medicines have been shown to reduce sleep latency and increase subjective and objective measures of sleep quality. Research into their molecular components revealed that their sedative and sleep-promoting properties rely on interactions with various neurotransmitter systems in the brain. Gamma-aminobutyric acid (GABA) is an inhibitory neurotransmitter that plays a major role in controlling different vigilance states. GABA receptors are the targets of many pharmacological treatments for insomnia, such as benzodiazepines. Here, we perform a systematic analysis of studies assessing the mechanisms of action of various herbal medicines on different subtypes of GABA receptors in the context of sleep control.
    [Show full text]
  • Profile Profile Profile Profile Uses and Administration Adverse Effects And
    640 Antihistamines Propiomazine Hydrochloride {BANM, r!NNMJ P..r�p�rc:Jti()n.� ............................ m (details are given in Volume B) propiorf,azina; to o azine; Chiorhydrate ProprietaryPreparations HidrodoruroPropi<;>rn deazini HydrochloridP pium; f1ponvtot,la3Y!Ha China: Qi Qi Hung. : de; Single-ingredient Preparafions. Loderixt. CIH'f); rMAPOX!10p!'\A. C;cJcl1_,--N_,QS,HCI�3.76_91 Rupatadine is an antihistamine with platelet-activating CAS 240) 5-9. factor (PAF) antagonist activity that is used for the Terfenadine (BAN, USAN, r!NN) treatment of allergic rhinitis (p. 612.1) and chronic 1 idiopathic urticaria (p. 612.3). It is given as the fumarate although doses are expressed in terms of the base; rupatadine fumarate 12.8 mg is equivalent to about 10 mg of rupatadine. The usual oral dose is the equivalent of 10 mg once daily of rupatadine. Izquierdo I. et a!. Rupatadine: a new selective histamine HI receptor and platelet-activating factor (PAF) antagonist: a review of pharmacological profile and clinical management of allergic rhinitis. Drugs Today 2003; 39: 451-68. 2. Kearn SJ,Plosker GL. Rupatadine: a review of its use in the management of allergic disorders. Drugs 2007; 67: 457-74. 3. Fantin et at. International Rupatadine study group. A 12-week 5, 8: (Terfenadine). A white or almost white, placebo-controlled study of rupatadine 10 mg once daily compared with Ph. Bur. cetirizine IO mg once daily, in the treatment of persistent allergic crystalline powder. It shows polymorphism. Very slightly rhinitis. Allergy 2008; 63: 924-3 1. soluble in water and in dilute hydrochloric acid; freely 4.
    [Show full text]
  • Quifenadine Hydrochloride/Thiethylperazine 591 Breast Milk; Its Active Metabolite, Fexofenadine, Was Excreted in 2
    Quifenadine Hydrochloride/Thiethylperazine 591 breast milk; its active metabolite, fexofenadine, was excreted in 2. Honig P, et al. Effect of erythromycin, clarithromycin and azi- rhinitis (p.565) and conjunctivitis (p.564) and skin disorders such limited amounts. thromycin on the pharmacokinetics of terfenadine. Clin Pharma- as urticaria (p.565). col Ther 1993; 53: 161. 1. American Academy of Pediatrics. The transfer of drugs and oth- 3. Biglin KE, et al. Drug-induced torsades de pointes: a possible The maximum oral dose of terfenadine is 120 mg daily given ei- er chemicals into human milk. Pediatrics 2001; 108: 776–89. interaction of terfenadine and erythromycin. Ann Pharmacother ther as 60 mg twice daily or 120 mg in the morning; a starting Correction. ibid.; 1029. Also available at: 1994; 28: 282. dose of 60 mg daily in a single dose or in two divided doses is http://aappolicy.aappublications.org/cgi/content/full/ 4. Fournier P, et al. Une nouvelle cause de torsades de pointes: as- pediatrics%3b108/3/776 (accessed 08/04/04) recommended for rhinitis and conjunctivitis. Children who are sociation terfenadine et troleandomycine. Ann Cardiol Angeiol over 12 years of age and weigh more than 50 kg may receive the 2. Lucas BD, et al. Terfenadine pharmacokinetics in breast milk in (Paris) 1993; 42: 249–52. lactating women. Clin Pharmacol Ther 1995; 57: 398–402. usual adult dosage. Antidepressants. Cardiac abnormalities have been reported in For dosage in renal impairment see below. Effects on the liver. Three episodes of acute hepatitis with 2 patients taking fluoxetine with terfenadine.1,2 Similarly, the use jaundice occurred in a patient taking terfenadine intermittently Administration in renal impairment.
    [Show full text]
  • Insomnia in the Elderly: Update on Assessment and Management
    To see other CME articles, go to: www.cmegeriatrics.ca www.geriatricsjournal.ca If you are interested in receiving this publication on a regular basis, please consider becoming a member. INSOMNIA IN THE ELDERLY: UPDATE ON ASSESSMENT AND MANAGEMENT Canadian Geriatrics Society Abstract Insomnia disorder is one of the most common sleep-wake disorders seen Soojin Chun in the geriatric population, and is associated with multiple psychiatric MSc., MD FRCP(C) and medical consequences. Insomnia is a subjective complaint of Geriatric Psychiatry difficulty falling and/or staying asleep, or experiencing non-restorative Subspecialty Resident sleep, associated with significant daytime consequences including (PGY-6), University of difficulty concentrating, fatigue and mood disturbances. There is no Ottawa single diagnostic tool to assess insomnia. Consequently, an insomnia assessment requires thorough history taking including a sleep inquiry, Elliott Kyung Lee medical history, psychiatric history, substance use history and a relevant MD, FRCP(C), D. ABPN physical examination. Insomnia is often multifactorial in origin, and Sleep Med, Addiction routinely is associated with multiple other psychiatric and medical Psych, D. ABSM, F. AASM, disorders. Therefore, predisposing, precipitating and perpetuating factors F. APA, Sleep Specialist, must be carefully examined in the context of an evaluation of insomnia Royal Ottawa Mental symptoms. Other specific sleep assessments (e.g., overnight Health Centre, Assistant polysomnography) can be completed to rule out other sleep-wake Professor, University of disorders. For management, a cognitive-behavioural approach (including Ottawa sleep restriction therapy, stimulus control therapy) is commonly accepted as an effective, first-line treatment for insomnia disorder. Corresponding Author: A brief version of CBT-I focusing on behavioural interventions (Brief Elliott Kyung Lee Behavioural Treatment of Insomnia, BBT-I) has also demonstrated efficacy in the geriatric patient population.
    [Show full text]